Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
- 28 November 2005
- Vol. 24 (12) , 2065-2070
- https://doi.org/10.1016/j.vaccine.2005.11.022
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox VirusJournal of Virology, 2005
- Zoonotic poxvirus infections in humansCurrent Opinion in Infectious Diseases, 2004
- US Military Smallpox Vaccination Program ExperienceJAMA, 2003
- Clinical Responses to Undiluted and Diluted Smallpox VaccineNew England Journal of Medicine, 2002
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Poxvirus Dilemmas — Monkeypox, Smallpox, and Biologic TerrorismNew England Journal of Medicine, 1998
- Immunologic Responses to Vaccinia Vaccines Administered by Different Parenteral RoutesThe Journal of Infectious Diseases, 1997
- Passage history, properties and applicability of the attenuated vaccinia virus strain MVAInfection, 1975
- MVA-Stufenimpfung gegen PockenDeutsche Medizinische Wochenschrift (1946), 1974
- Complications of Smallpox Vaccination, 1968New England Journal of Medicine, 1969